Pharma lags behind healthcare in AI adoption, but many expect wider use in next few years, study finds
29 Feb 2024
Pharma companies are trailing behind healthcare in AI adoption by a wide margin, according to a new study. Only 20% of pharma professionals versus 40% of healthcare providers say the new technology is already in use, according to management consultancy Berkeley Research Group’s (BRG) report.
While the gap will likely persist, AI use is expected to gain wide acceptance and implementation in both industries, with more than half of pharma and 75% of healthcare professionals expecting it within three years.
Preview
Source: EndPoints
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.